Deutsche Bank AG Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Deutsche Bank initiated a position in DENTSPLY SIRONA, purchasing 267,407 shares worth approximately $2.84 million. Institutional investors and hedge funds collectively own 95.70% of the company.
• Two directors recently bought shares, contributing to 35,160 shares of insider purchases valued at about $351,179 over the past 90 days.
• DENTSPLY SIRONA beat quarterly EPS and revenue estimates, but revenue fell 4.1% year over year and the company reported a negative net margin. Analysts maintain a consensus “Hold” rating with a $13.54 target price, compared with shares recently trading at $10.93.

Deutsche Bank AG bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 267,407 shares of the medical instruments supplier's stock, valued at approximately $2,837,000. Deutsche Bank AG owned 0.13% of DENTSPLY SIRONA at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of New York Mellon Corp acquired a new stake in DENTSPLY SIRONA during the second quarter worth about $16,408,000. Focus Partners Advisor Solutions LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $251,000. State of Wyoming acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $250,000. GSA Capital Partners LLP bought a new position in DENTSPLY SIRONA in the second quarter valued at approximately $483,000. Finally, Bank of America Corp DE increased its stake in DENTSPLY SIRONA by 18.3% in the first quarter. Bank of America Corp DE now owns 2,432,457 shares of the medical instruments supplier's stock valued at $28,217,000 after acquiring an additional 375,994 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Brian P. Mckeon purchased 10,000 shares of the stock in a transaction on Friday, June 12th. The stock was purchased at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the acquisition, the director owned 10,000 shares in the company, valued at $101,200. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Brian T. Gladden acquired 9,985 shares of DENTSPLY SIRONA stock in a transaction dated Monday, June 15th. The stock was purchased at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the purchase, the director owned 61,849 shares in the company, valued at approximately $619,726.98. The trade was a 19.25% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 35,160 shares of company stock valued at $351,179 over the last ninety days. 0.46% of the stock is owned by company insiders.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $10.93 on Thursday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA Inc. has a 52 week low of $9.40 and a 52 week high of $14.86. The firm has a market cap of $2.18 billion, a PE ratio of -3.97, a price-to-earnings-growth ratio of 1.38 and a beta of 0.85. The firm's fifty day moving average is $12.07 and its 200-day moving average is $11.77.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. The business had revenue of $898.00 million during the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.DENTSPLY SIRONA's revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the company earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a research note on Monday, August 10th. Weiss Ratings reissued a "sell (e+)" rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Mizuho dropped their price objective on DENTSPLY SIRONA from $16.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 6th. Barclays raised their price objective on DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an "underweight" rating in a research note on Monday. Finally, UBS Group lowered their target price on DENTSPLY SIRONA from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $13.54.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source